Superstring Capital Management LP Arcellx, Inc. Transaction History
Superstring Capital Management LP
- $79.3 Billion
- Q2 2024
A detailed history of Superstring Capital Management LP transactions in Arcellx, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 59,133 shares of ACLX stock, worth $4.95 Million. This represents 4.11% of its overall portfolio holdings.
Number of Shares
59,133Holding current value
$4.95 Million% of portfolio
4.11%Shares
1 transactions
Others Institutions Holding ACLX
# of Institutions
176Shares Held
45.6MCall Options Held
53.6KPut Options Held
53.7K-
Perceptive Advisors LLC New York, NY3.89MShares$325 Million6.21% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.85MShares$322 Million8.59% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$313 Million19.51% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$294 Million0.0% of portfolio
-
Sr One Capital Management, LP2.35MShares$196 Million56.87% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.67B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...